New research suggests that coffee may lower the risk of AFib episodes in people who already have the condition. Cardiologists ...

A multicenter clinical trial has found that intratracheal steroids do not reduce the risk of lung disease or death in ...

OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer ...

The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting ...

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological ...

Researchers led by St Michael's Hospital in Toronto report that ketogenic diets are associated with modest reductions in ...

Clinical trials are more connected and more closely examined than ever. Inspection readiness isn’t a last-minute document ...

Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential ...

Multicenter, randomized, controlled study will evaluate Company’s next-generation multichannel TMS technology in reducing ...

“Endotyping-informed therapy in the MRI-guided intervention arm led to a reduction in angina burden and an improvement in health-related quality of life,” reported the principal investigator Colin ...

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- ...

The findings of two RCTs suggest estetrol has promise as an additional estrogen formulation option for postmenopausal women.